TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.

V Conteduca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.